Patents Assigned to TenaRx, Inc.
  • 4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof
    Patent number: 12729205
    Abstract: 4-Alkoxypyrrolo[2,1-f][1,2,4]triazine compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of 4-alkoxypyrrolo[2,1-f][1,2,4]triazine compounds or analogs thereof, in the treatment of disorders characterized by overexpression of DYRK1A (e.g., cancer, Down syndrome, Alzheimer's disease, diabetes, viral infections, and osteoarthritis).
    Type: Grant
    Filed: June 23, 2023
    Date of Patent: September 8, 2026
    Assignee: TenaRx, Inc.
    Inventors: Gopi Kumar Mittapalli, Chi Ching Mak, Lewis Daniel Turner, Brian Joseph Hofilena, Ramkrishna Reddy Vakiti, Brian Walter Eastman, David Mark Wallace